Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.
Site Search
Showing 1 - 4 of 4 results
Press Release
|
Sept. 23, 2021
|
3 min read
Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance
Press Release
|
Jan. 4, 2022
|
4 min read
Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation
Press Release
|
Jan. 5, 2022
|
5 min read
Today, the Cystic Fibrosis Foundation announced that it has awarded up to $2.17 million to Beyond Air® to support the development of a portable inhaled nitric oxide treatment for nontuberculous mycobacteria, difficult-to-treat bacteria that infect the lungs of people with cystic fibrosis.
Press Release
|
Feb. 16, 2021
|
4 min read